Health and wellness platform Healthify (formerly HealthifyMe) has secured $45 million in funding to drive global expansion into the US market with AI-powered wellness solutions, aiming to boost corporate wellness and achieve operational profitability.
The round was led by Khosla Ventures and LeapFrog Investments, with participation from Claypond Capital, Ranjan Pai’s family office. This funding, totaling approximately $125 million in equity, supports Healthify’s ambitious expansion into the US market and its commitment to delivering worldwide AI-driven, personalized wellness solutions.
Founded by Tushar Vashisht, Sachin Shenoy, and Mathew Cherian, Healthify combines AI technology, wearable devices, and personalized coaching to support users in achieving their fitness and wellness goals. The platform serves over 40 million users across 300 cities in India and aims to adapt its AI capabilities to fit the cultural, dietary, and linguistic needs of its expanding international audience.
This latest funding enables Healthify to fine-tune its AI to understand local fitness habits, food preferences, and dialects, making the user experience seamless and personalized as it enters the US market.
US Market Entry and B2B Growth Strategy
Healthify has conducted successful alpha tests in the US, focusing on localizing its app to resonate with users’ cultural and dietary needs. The company plans to launch its platform in the US within months, and is also enhancing its B2B strategy to grow through corporate wellness partnerships. By collaborating with the diagnostics, insurance, and pharmaceutical industries, Healthify aims to support sustainable health outcomes at scale.
Tushar Vashisht, Co-founder and CEO of Healthify said, “After delivering outcomes at scale in India with our unique blend of AI and human coaching, we’re thrilled to bring this approach to the US, the world’s largest health and fitness market. With this funding, we’re one step closer to putting a high-acuity health coach in every person’s pocket.”
On the financial front, Healthify’s operations in India have already reached operational profitability. The company forecasts EBITDA-positive by the fiscal year-end, signaling financial solid health. With an eye on profitability, Healthify has maintained robust user engagement while diversifying its revenue streams through its B2B vertical.
Healthify Funding Overview
The latest round includes a $20 million addition to an earlier tranche in 2023, pushing Healthify closer to its Series D target. Since its Series C round in 2021, led by Khosla Ventures and LeapFrog, the company has received substantial backing, underscoring investor confidence in Healthify’s vision and performance.
With significant financial backing, Healthify’s entry into the US market and its enhanced AI capabilities are set to redefine wellness for diverse communities. Healthify’s growing global footprint underscores its commitment to delivering accessible, AI-driven health solutions that transcend cultural and geographic boundaries.
Stay ahead of the curve and follow IndiaTechDesk on Facebook, Twitter and Linkedin for in-depth news of market trends, funding updates, and regulatory changes affecting startups in India.
Read More:
- Westbridge Capital Leads $21M Series C Investment in DealShare!
- RagaAI Secures $4.7M Seed Funding to Pioneer AI Safety and Reliability Testing
- Japan’s Beyond Next Ventures invests in Indian AI-based startup Myelin Foundry
- Indian Drone Startup Garuda Aerospace Bags $3 Million Boost Amidst Soaring Orders
- B2B Retail Tech Startup Arzoo raises $70 million in its Series B
